跳至主要内容
临床试验/NCT05998551
NCT05998551招募中不适用

Effectiveness of Single Shot Intra-thecal Analgesia in Multiparous Women Scheduled for Normal Vaginal Delivery.

Ain Shams University1 个研究点 分布在 1 个国家目标入组 75 人开始时间: 2023年1月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
招募中
入组人数
75
试验地点
1
主要终点
Duration of pain relief

研究概览

简要总结

Effectiveness of single shot intra-thecal analgesia in multiparous women scheduled for normal vaginal delivery

详细描述

Labor is a physiological and natural process, as well as a complicated and subjective experience.Except for a few women, childbirth is unquestionably a painful experience. Women's understanding of delivery's pain is influenced by various factors, making each experience special. As opposed to other painful life events, labor pain consistently ranks high on the pain rating scale.

In this study ,the investigators are going to investigate the effectiveness and safety of intrathecal analgesia for labour using bupivacaine with fentanyl or dexmedetomidine.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

Computer generated number lists and use of sealed opaque envelopes , double blinded trial

入排标准

年龄范围
22 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

Dexmedetomidine Group

Active Comparator

participants will receive intrathecal injection of 5mg (1ml) of 0.5% hyperbaric bupivacaine + 1 ml contain 5μg dexmedetomidine(0.05ml dexmedetomidine in insulin syringe+ 0.95ml normal saline).

干预措施: Dexmedetomidine (Drug)

Fentanyl group

Active Comparator

participants will receive intrathecal injection of 5 mg (1ml) of 0.5% hyperbaric bupivacaine + 1 ml contain 12.5μg fentanyl(0.25ml fentanyl in insulin syringe+ 0.75ml normal saline).

干预措施: Fentanyl (Drug)

Control group

Active Comparator

participants will receive intrathecal injection of 5mg (1ml) of 0.5% hyperbaric bupivacaine + 1 ml normal saline

干预措施: Bupivacaine Hcl 0.5% Inj (Drug)

结局指标

主要结局

Duration of pain relief

时间窗: Up to 6 hours after intrathecal injection

The duration of pain relief will be defined as the duration from intrathecal injection till the VAS became more than 4

maximum level of sensory block

时间窗: 15 min after the intrathecal injection

Temperature will be assessed using methylated soaked swabs on both sides of the body

visual analogue scale (VAS) of the labour pain

时间窗: 6 hours after intrathecal injection

The VAS (ranging from 0 = pain-free up to 10 = worst imaginable pain) of the labour pain will be recorded before the intrathecal injection, every 5 min for the first 20 min, then every 30 min for 6 hours

S1 regression time

时间窗: 6 hours after intrathecal injection

S1 regression time will be defined as the time from intrathecal injection to sensory regression to S1 dermatome

analgesic onset time

时间窗: within 15 minutes after intrathecal injection

The analgesia onset time will be defined as the time from intrathecal injection until the VAS became less than 4

次要结局

  • Maternal heart rate(6 hours post operative)
  • Maternal blood pressure(6 hours post operative)
  • Fetal APGAR score(till 5 minutes after delivery)
  • Post operative nausea and vomiting(6 hours post operative)
  • Post operative urinary retention(6 hours post operative)
  • Fetal heart sounds(from intrathecal injection till delivery)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验